Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Prevention of CIPN in Breast Cancer
NCT04780854Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Nov 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Cairo University. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04780854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780854.